Inflammatory Bowel Diseases Clinical Trials in Philadelphia, Pennsylvania

3 studies are recruiting for inflammatory bowel diseases in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

    The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD). The study will last about 172 weeks and may include up to 44 visits. Additional treatment may be available to participants via a Contin…

    Stage
    Phase 3
    Ages
    2 to 19
    Site
    Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania
    Locations
    68 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT04844606 on ClinicalTrials.gov

  2. BOOM-IBD2 Pivotal Clinical Trial

    Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a nerve near the tail…

    Stage
    Not phased
    Ages
    18 to 85
    Site
    Pennsylvania Hospital, Philadelphia, Pennsylvania
    Locations
    19 in total
    Run by
    Boomerang Medical

    See if you can join NCT06571669 on ClinicalTrials.gov

  3. Duloxetine in Inflammatory Bowel Diseases

    This open-label, prospective, single-arm pilot study investigates the use of duloxetine, a central neuromodulator, for improving psychological distress and functional impairment in adults with inflammatory bowel disease (IBD). The study focuses on patient-reported outcomes related to anxiety, depre…

    Stage
    Phase 2
    Ages
    24 and older
    Site
    University of Pennsylvania, Philadelphia, Pennsylvania
    Run by
    University of Pennsylvania

    See if you can join NCT07431606 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.